REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biotechnology Consulting And Investment Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmacies and Drug Stores | Department Stores | All Other Nondepository Credit Intermediation | Engineering Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Management of Companies and Enterprises | All Other Miscellaneous Ambulatory Health Care Services
Full name: Biotechnology Consulting And Investment Sp. z o.o. Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Biotechnology Consulting And Investment Sp. z o.o. is an enterprise in Poland, with the main office in Brody. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on October 17, 2013. 6 - 20 (2015) employees currently work for Biotechnology Consulting And Investment Sp. z o.o.. In its most recent financial highlights, the company reported a net sales revenue increase of 950% in 2023. There was a total negative growth of 0.21% in Biotechnology Consulting And Investment Sp. z o.o.’s total assets over the same period. Biotechnology Consulting And Investment Sp. z o.o.’s net profit margin increased by 4268.42% in 2023.

Headquarters
Brody 32
Brody; Lubuskie; Postal Code: 68-343

Contact Details: Purchase the Biotechnology Consulting And Investment Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Biotechnology Consulting And Investment Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Biotechnology Consulting And Investment Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Biotechnology Consulting And Investment Sp. z o.o. report to view the information.
Incorporation Date:
October 17, 2013
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
96%
Subsidiaries
Medcervin Sp. z o.o.
29.21%
Company Performance
Financial values in the chart are available after Biotechnology Consulting And Investment Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
950%▲
Total operating revenue
833.84%▲
Operating profit (EBIT)
31.33%▲
Net Profit (Loss) for the Period
31.33%▲
Total assets
-0.21%▼
Total equity
-0.51%▼
Operating Profit Margin (ROS)
4268.42%▲
Net Profit Margin
4268.42%▲
Return on Equity (ROE)
0.23%▲
Quick Ratio
-0%
Cash Ratio
-0.77%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo